This inventor holds 1 USPTO granted patent. Top assignee: Stellenbosch University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Paul William Reader: Innovator in Malaria Treatment
Introduction
Paul William Reader is a notable inventor based in Stellenbosch, South Africa. He has made significant contributions to the field of medical science, particularly in the treatment of malaria. His innovative approach combines peptides and polymers to create effective therapeutic solutions.
Latest Patents
Reader holds a patent for a "Conjugate for treating malaria." This invention involves a peptide-polymer conjugate designed to combat malaria infections, especially those that are terminal or drug-resistant. The conjugate is formed from a polymer that is co-valently attached to a peptide with activity against malaria parasites. The peptide is a cyclic decapeptide derived from a group of compounds known for their antimicrobial properties. The polymer used is hydrophilic and biocompatible, such as poly(N-vinylpyrrolidone) (PVP). Additionally, the polymer chains can be modified with a hydrophilic targeting ligand that specifically targets infected red blood cells.
Career Highlights
Reader is affiliated with Stellenbosch University, where he conducts research and develops innovative solutions for pressing health issues. His work has garnered attention for its potential impact on malaria treatment, a disease that continues to affect millions worldwide.
Collaborations
Reader collaborates with esteemed colleagues, including Lubertus Klumperman and Marina Rautenbach. Their combined expertise enhances the research and development of effective treatments for malaria.
Conclusion
Paul William Reader's contributions to malaria treatment through his innovative peptide-polymer conjugate exemplify the importance of research in combating infectious diseases. His work not only highlights the potential for new therapeutic approaches but also underscores the collaborative efforts within the scientific community.